Diagnostics
The company will focus on its biggest divisions: aviation, power and healthcare.
Will a boom in genetic testing of tumors be a boon for Soon-Shiong?
The hearing will focus on the therapeutic potential and ethical issues of using CRISPR technology to alter human DNA.
Progenity snagged $125M in funding that will allow the company to accelerate development of its gastrointestinal platform.
Patrick Soon-Shiong touted sales of his closely scrutinized test without revealing the purchaser was on his payroll.
Cancer treatment is moving rapidly toward personalized medicine and precision medicine thanks to genetic insight.
Vikram Bajaj joined Grail only a year ago.
The Annual Report is available on the Company’s website at www.gtglabs.com
Future generations might look back and wish their parents and grandparents had added these three top stocks to their portfolios today.
GIMDx of Carlsbad, California acquired exclusive China OEM and distribution rights to oncology diagnostic products made by IncellDx, a Menlo Park company.
PRESS RELEASES